Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-08-08

Clinical Trial Update: Flouro-Gem in Adenocarcinoma of the Pancreas (GEFLUPAN) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Flouro-Gem in pancreatic adenocarcinoma (GEFLUPAN) has completed enrollment; results not provided in snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Flouro-Gem (flouro-gem)

Snippet

Sponsor: Menoufia University | Conditions: Cancer of Pancreas, Chemotherapy Effect | Phase 2 | Status: COMPLETED